Martine Bagot
#134,460
Most Influential Person Now
Researcher
Martine Bagot's AcademicInfluence.com Rankings
Martine Bagotcomputer-science Degrees
Computer Science
#6099
World Rank
#6430
Historical Rank
Machine Learning
#1869
World Rank
#1894
Historical Rank
Artificial Intelligence
#2116
World Rank
#2152
Historical Rank
Database
#3216
World Rank
#3352
Historical Rank
Download Badge
Computer Science
Martine Bagot's Degrees
- PhD Computer Science Université Paris Cité
Similar Degrees You Can Earn
Why Is Martine Bagot Influential?
(Suggest an Edit or Addition)Martine Bagot's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). (1996) (892)
- European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. (2008) (412)
- Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial (2017) (388)
- EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. (2011) (367)
- Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. (2004) (356)
- European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. (2017) (339)
- Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. (2018) (330)
- Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. (2005) (286)
- Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. (2000) (286)
- Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. (2015) (283)
- What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature (2010) (274)
- Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. (2002) (272)
- Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. (2001) (262)
- Vascular skin symptoms in COVID‐19: a French observational study (2020) (259)
- IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro (2010) (247)
- Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. (2007) (235)
- Open trial of ciclosporin treatment for Stevens–Johnson syndrome and toxic epidermal necrolysis (2010) (221)
- Nonhepatosplenic γδ T-Cell Lymphoma: A Subset of Cytotoxic Lymphomas With Mucosal or Skin Localization (1998) (201)
- Guidelines on the use of extracorporeal photopheresis (2013) (182)
- Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France (2020) (176)
- CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC). (1999) (175)
- Interleukin-7 is a growth factor for Sézary lymphoma cells. (1992) (169)
- Evaluation of the potential role of cytokines in toxic epidermal necrolysis. (2004) (167)
- CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. (2004) (161)
- Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? (2010) (150)
- Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. (1995) (148)
- Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors (2000) (146)
- Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. (1996) (146)
- Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature (2010) (144)
- Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies (2010) (144)
- Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients (2013) (143)
- European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes (2017) (141)
- Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis. (1995) (140)
- Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas. (2004) (139)
- A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome. (1995) (139)
- What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature (2010) (136)
- Granuloma faciale: a clinicopathologic study of 66 patients. (2005) (136)
- Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma. (2016) (135)
- Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. (1992) (132)
- CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. (2001) (132)
- Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas. (1999) (131)
- The optimal use of bexarotene in cutaneous T‐cell lymphoma (2007) (131)
- Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. (2000) (129)
- CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. (2015) (121)
- Minimizing adverse side‐effects of oral bexarotene in cutaneous T‐cell lymphoma: an expert opinion (2006) (119)
- Ipilimumab-induced acute severe colitis treated by infliximab. (2013) (118)
- The Clinical Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis: Data From a French Nationwide Study of Fifty‐Seven Patients (2015) (117)
- Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. (2007) (116)
- Therapeutic management of DRESS: a retrospective study of 38 cases. (2015) (113)
- Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. (1998) (112)
- Hepatitis C virus in dermatology. A review. (1995) (109)
- Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma (1998) (109)
- Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. (2000) (109)
- Papular-purpuric "gloves and socks" syndrome: primary infection with parvovirus B19? (1991) (105)
- Primary cutaneous pleomorphic small T-cell lymphoma : a review of 11 cases (1995) (104)
- CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer (2006) (104)
- The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients (2018) (103)
- Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type (2016) (103)
- Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. (1998) (100)
- Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist? (2012) (95)
- Autoimmune diabetes induced by PD-1 inhibitor—retrospective analysis and pathogenesis: a case report and literature review (2017) (93)
- Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases. (1990) (90)
- Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides. (1998) (89)
- Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012. (2012) (88)
- ERK and PDE4 cooperate to induce RAF isoform switching in melanoma (2011) (88)
- Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium (2017) (87)
- Long‐term efficacy and safety of alemtuzumab in advanced primary cutaneous T‐cell lymphomas (2014) (87)
- Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis. (2000) (85)
- Neutrophilic dermatoses as systemic diseases. (2014) (85)
- Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force. (2018) (82)
- Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France. (2014) (81)
- Active Chronic Sarcoidosis is Characterized by Increased Transitional Blood B Cells, Increased IL-10-Producing Regulatory B Cells and High BAFF Levels (2012) (81)
- Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop (2015) (80)
- IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial. (2019) (79)
- Anti-PD1-induced collagenous colitis in a melanoma patient. (2016) (77)
- T-cell receptor-γ/δ bearing lymphocytes in normal and inflammatory human skin (1990) (76)
- c-Kit mutants require hypoxia-inducible factor 1α to transform melanocytes (2010) (76)
- Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases. (2012) (75)
- Significance of circulating T-cell clones in Sezary syndrome. (2006) (75)
- Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients. (2016) (75)
- A Review of its Pharmacological Properties and Therapeutic Efficacy in the Management of Psoriasis (1996) (73)
- Evidence‐based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists (2010) (72)
- BCL2 and JUNB abnormalities in primary cutaneous lymphomas (2004) (70)
- Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases. (2011) (70)
- Cutaneous Destombes–Rosai–Dorfman disease: absence of detection of HHV‐6 and HHV‐8 in skin (2002) (70)
- The Spectrum of Cutaneous Lymphomas in HIV infection: a study of 21 cases. (1999) (68)
- Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma. (1998) (67)
- SC5 mAb Represents a Unique Tool for the Detection of Extracellular Vimentin as a Specific Marker of Sézary Cells1 (2006) (67)
- Pilotropic cutaneous T-cell lymphoma without mucinosis. A variant of mycosis fungoides? French Study Group of Cutaneous Lymphomas. (1996) (66)
- Primary cutaneous pleomorphic small T-cell lymphoma. A review of 11 cases. The French Study Group on Cutaneous Lymphomas. (1995) (65)
- Pilotropic Cutaneous T-Cell Lymphoma Without Mucinosis: A Variant of Mycosis Fungoides? (1996) (65)
- Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas (2014) (64)
- Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro. (1991) (63)
- Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases (2015) (60)
- IL-10 producing regulatory B cells in mice and humans: state of the art. (2012) (60)
- Killer cell immunoglobulin‐like receptor expression delineates in situ Sézary syndrome lymphocytes (2003) (59)
- PARKIN Inactivation Links Parkinson's Disease to Melanoma. (2016) (59)
- Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study. (2005) (58)
- Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin. (1998) (57)
- Maintenance therapy in cutaneous T-cell lymphoma: who, when, what? (2007) (56)
- Posaconazole treatment of extensive skin and nail dermatophytosis due to autosomal recessive deficiency of CARD9. (2015) (56)
- Value of clonality studies of cutaneous T lymphocytes in the diagnosis and follow‐up of patients with mycosis fungoides (1998) (55)
- A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas. (1999) (55)
- CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome. (2008) (55)
- Absolute CD3+ CD158k+ lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumour burden in Sézary syndrome (2010) (54)
- Subcutaneous Panniculitis-like T-cell Lymphoma: Immunosuppressive Drugs Induce Better Response than Polychemotherapy. (2017) (53)
- Polymerase Chain Reaction Analysis of Immunoglobulin Gene Rearrangement in Cutaneous Lymphoid Hyperplasias (1999) (52)
- Early-Onset Atopic Dermatitis in Children: Which Are the Phenotypes at Risk of Asthma? Results from the ORCA Cohort (2015) (51)
- Lichen planus and hepatitis C virus (HCV)‐related chronic hepatitis: evaluation of HCV genotypes (1995) (51)
- IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma. (2014) (51)
- Immunosuppressive effects of 1,2 5‐dihydroxyvitamin D3 and its analogue calcipotriol on epidermal cells (1994) (50)
- Sjögren's syndrome and cutaneous B cell lymphoma revealed by anetoderma. (1993) (49)
- CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells. (2015) (49)
- Characterization of CXCL13+ Neoplastic T Cells in Cutaneous Lesions of Angioimmunoblastic T-cell Lymphoma (AITL) (2007) (48)
- Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients (2020) (48)
- Retrospective Multicentric Study of 25 Kimura Disease Patients: Emphasis on Therapeutics and Shared Features with Cutaneous IgG4-Related Disease (2015) (48)
- Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome (2016) (48)
- Crosstalk between Tumor T Lymphocytes and Reactive T Lymphocytes in Cutaneous T Cell Lymphomas (2001) (47)
- Large International Validation of ABSIS and PDAI Pemphigus Severity Scores. (2019) (47)
- Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy. (2013) (47)
- MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis. (2012) (46)
- Neutrophilic Skin Lesions in Autoimmune Connective Tissue Diseases (2014) (45)
- Intraepidermal localization of the clone in cutaneous T-cell lymphoma. (1992) (45)
- Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in sezary syndrome patients. (2005) (44)
- Did Whatsapp® reveal a new cutaneous COVID‐19 manifestation? (2020) (44)
- Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis. (2006) (44)
- Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort (2017) (44)
- A framework for improving the quality of care for people with psoriasis (2012) (44)
- Phenotypic and functional changes in dermal primary fibroblasts isolated from intrinsically aged human skin (2016) (43)
- Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients. (2011) (42)
- Specificity of monoclonal antibody anti‐T‐6 for Langerhans' cells in normal human skin (1982) (42)
- Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis. (2013) (42)
- Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis (2011) (42)
- Vemurafenib-induced neutrophilic panniculitis. (2012) (42)
- Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients (2020) (41)
- Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab. (2009) (41)
- Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis. (2016) (41)
- Epigenomic Analysis of Sézary Syndrome Defines Patterns of Aberrant DNA Methylation and Identifies Diagnostic Markers. (2016) (41)
- European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis (2017) (41)
- TWEAK Affects Keratinocyte G2/M Growth Arrest and Induces Apoptosis through the Translocation of the AIF Protein to the Nucleus (2012) (40)
- Lack of evidence of HTLV-I/II infection in T CD8 malignant or reactive lymphoproliferative disorders in France: a serological and/or molecular study of 169 cases. (1995) (40)
- Post-transplant cutaneous T-cell lymphomas. (2005) (40)
- Histopathologic Diagnosis of Lymphomatous Versus Inflammatory Erythroderma: A Morphologic and Phenotypic Study on 47 Skin Biopsies (2010) (40)
- Functional characterization of an IL-7-dependent CD4+CD8αα+ Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma (2000) (40)
- Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD. (2012) (39)
- Relative frequency and survival of patients with primary cutaneous lymphomas: data from a single‐centre study of 203 patients (2006) (39)
- Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL‐10 production (2000) (39)
- Emergency department diagnosis and management of skin diseases with real-time teledermatologic expertise. (2014) (39)
- Severe Aplastic Anemia Associated With Eosinophilic Fasciitis (2013) (39)
- Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5‐year‐long study (2016) (39)
- Primary cutaneous large B-cell lymphomas. (2000) (38)
- The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression. (2015) (38)
- Amicrobial pustulosis associated with autoimmune diseases: healing with zinc supplementation (2000) (38)
- Increased expression of a novel early activation surface membrane receptor in cutaneous T cell lymphoma cells. (2001) (38)
- Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab. (2017) (38)
- Natural history of allergic sensitization in infants with early‐onset atopic dermatitis: results from ORCA Study (2014) (38)
- Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity. (2017) (37)
- Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma (2012) (37)
- In vivo multiphoton imaging of human skin: assessment of topical corticosteroid-induced epidermis atrophy and depigmentation. (2012) (37)
- UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome. (2021) (36)
- Leucoderma associated with flares of erythrodermic cutaneous T‐cell lymphomas: four cases (2000) (36)
- Usefulness of KIR3DL2 to Diagnose, Follow-Up, and Manage the Treatment of Patients with Sézary Syndrome (2017) (36)
- Cutaneous B-cell lymphoma associated with follicular mucinosis. (1995) (35)
- Bullous Amyloidosis: Report of 3 Cases and Review of the Literature (1993) (35)
- Anetoderma may reveal cutaneous plasmacytoma and benign cutaneous lymphoid hyperplasia. (1995) (35)
- Influence of HLA class I- and class II-specific monoclonal antibodies on DR-restricted lymphoproliferative responses. I. Unseparated populations of effector cells. (1983) (35)
- Syringotropic mycosis fungoides: clinical and histologic features, response to treatment, and outcome in 19 patients. (2014) (35)
- CD158k/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides (2012) (35)
- Phase II Clinical Trial of Intratumoral Application of TG1042 (Adenovirus-interferon-γ) in Patients With Advanced Cutaneous T-cell Lymphomas and Multilesional Cutaneous B-cell Lymphomas. (2010) (34)
- Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma. (2012) (34)
- Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling. (2002) (34)
- Relationship between cutaneous polyarteritis nodosa (cPAN) and macular lymphocytic arteritis (MLA): Blinded histologic assessment of 35 cPAN cases. (2015) (34)
- Class II MHC antigen expression by human keratinocytes results from lympho-epidermal interactions and gamma-interferon production. (1986) (34)
- Prognostic value of histologic features of toxic epidermal necrolysis. (2013) (34)
- Synthetic retinoids inhibit the antigen presenting properties of epidermal cells in vitro. (1989) (33)
- BRAF inhibitor rechallenge in patients with advanced BRAF V600-mutant melanoma (2015) (33)
- IgA autoantibodies bind to pemphigus vulgaris antigen in a case of intraepidermal neutrophilic IgA dermatosis. (1991) (33)
- Follow-Up of Patients With Complete Remission of Locally Advanced Basal Cell Carcinoma After Vismodegib Discontinuation: A Multicenter French Study of 116 Patients. (2019) (33)
- Hepatitis C Virus in Dermatology (1995) (33)
- Gene expression profiling of human angiotropic primary melanoma: selection of 15 differentially expressed genes potentially involved in extravascular migratory metastasis. (2011) (32)
- Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation. (2007) (32)
- Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists (2015) (32)
- Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids (2015) (32)
- Folliculitis decalvans is characterized by a persistent, abnormal subepidermal microbiota (2020) (31)
- Do primary cutaneous non-T non-B CD4+CD56+ lymphomas belong to the myelo-monocytic lineage? (1998) (31)
- Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients. (2010) (30)
- Value of the CD8-CD3 Ratio for the Diagnosis of Mycosis Fungoides (2003) (30)
- Inflammatory vitiligo-like macules that simulate hypopigmented mycosis fungoides. (2003) (29)
- Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study * (2020) (29)
- A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type. (2018) (29)
- Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance (2008) (29)
- European dermatology forum – updated guidelines on the use of extracorporeal photopheresis 2020 – part 1 (2020) (29)
- Regulation of T-plastin expression by promoter hypomethylation in primary cutaneous T-cell lymphoma. (2012) (29)
- HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma. (2020) (28)
- Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease (2014) (28)
- A POSSIBLE PREDICTIVE TEST FOR GRAFT‐VERSUS‐HOST DISEASE IN BONE MARROW GRAFT RECIPIENTS: THE MIXED EPIDERMAL CELL‐LYMPHOCYTE REACTION (1986) (27)
- Interleukin‐7 receptor expression in cutaneous T‐cell lymphomas (1996) (27)
- Acquired C1 inhibitor deficiency revealing systemic lupus erythematosus. (1993) (27)
- Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow‐up study on 54 cases (1995) (27)
- Dramatic improvement of generalized prurigo nodularis with dupilumab (2019) (27)
- Changing antimalarial agents after inefficacy or intolerance in patients with cutaneous lupus erythematosus: A multicenter observational study (2018) (27)
- Intravenous immunoglobulins in difficult‐to‐treat ulcerated livedoid vasculopathy: five cases and a literature review (2013) (26)
- [Prognosis of primary cutaneous lymphomas]. (2002) (26)
- KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large‐cell lymphoma (2016) (26)
- Erythrodermic cutaneous T‐cell lymphoma with disseminated pustulosis. Production of high levels of interleukin‐8 by tumour cells (2001) (26)
- Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome. (2007) (26)
- Certolizumab pegol – A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn’s disease (2016) (26)
- Subcutaneous panniculitis‐like T‐cell lymphoma αβ: complete sustained remission with corticosteroids and methotrexate (2010) (25)
- Psoriatic arthritis screening by the dermatologist: development and first validation of the ‘PURE‐4 scale’ (2018) (25)
- Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial. (2016) (25)
- [Management of cutaneous T-cell lymphomas: Recommendations of the French Cutaneous Lymphoma Group]. (2010) (25)
- Teledermatology for COVID‐19 cutaneous lesions: substitute or supplement? (2020) (25)
- Genes involved in the WNT and vesicular trafficking pathways are associated with melanoma predisposition (2015) (25)
- Relevance of serum biomarkers associated with melanoma during follow-up of anti-CTLA-4 immunotherapy. (2016) (25)
- Oral desensitization in nickel allergy induces a decrease in nickel-specific T-cells (1995) (25)
- The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile. (2015) (25)
- Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma (2000) (25)
- Stevens–Johnson syndrome and toxic epidermal necrolysis: follow‐up of pulmonary function after remission (2015) (25)
- Dermatology today and tomorrow: from symptom control to targeted therapy (2019) (24)
- Recent discoveries in the genetics of melanoma and their therapeutic implications (2007) (24)
- Extranodal NK/T-Cell Lymphoma: Toward the Identification of Clinical Molecular Targets (2011) (24)
- Successful treatment of type II pityriasis rubra pilaris with secukinumab (2016) (24)
- Two Atypical Cases of Cutaneous Gamma/Delta T-Cell Lymphomas (2011) (23)
- Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response (2015) (23)
- Functional characterization of neurotensin receptors in human cutaneous T cell lymphoma malignant lymphocytes. (2001) (23)
- Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak* (2021) (23)
- Cutaneous macroglobulinosis: a report of 2 cases. (2010) (23)
- Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft‐versus‐host disease (2017) (23)
- Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies (2020) (22)
- Squamous Cell Carcinoma Following Photodynamic Therapy for Cutaneous Bowen's Disease in a Series of 105 Patients. (2016) (22)
- KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting. (2017) (22)
- Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases. (1999) (22)
- Antiproliferative effect of semaphorin 3F on human melanoma cell lines. (2006) (22)
- Efalizumab-induced bullous pemphigoid. (2010) (22)
- The mixed epidermal cell lymphocyte‐reaction is the most predictive factor of acute graft‐versus‐host disease in bone marrow graft recipients (1988) (22)
- KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell death. (2014) (21)
- Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas. (2010) (21)
- Identification of Cell Surface Molecules Characterizing Human Cutaneous T-cell Lymphomas (2002) (21)
- Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry * (2020) (21)
- Association of autoimmunity and long‐term complete remission in patients with Sézary syndrome treated with mogamulizumab (2018) (20)
- A Large French Case-Control Study Emphasizes the Role of Rare Mc1R Variants in Melanoma Risk (2014) (20)
- Cetuximab as first-line monotherapy in patients with skin unresectable squamous cell carcinoma: Final results of a phase II multicenter study. (2010) (20)
- Atypical Spitzoid Melanocytic Neoplasms With Angiotropism: A Potential Mechanism of Locoregional Involvement (2011) (20)
- NKG2D ligands expression and NKG2D-mediated NK activity in Sezary patients. (2009) (20)
- A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies (2015) (20)
- Ultrasound-guided core needle biopsy of superficial lymph nodes: an alternative to fine-needle aspiration cytology for the diagnosis of lymph node metastasis in cutaneous melanoma (2015) (20)
- Dendritic cells in the skin – potential use for melanoma treatment (2009) (20)
- [Non epidermotropic T lymphoma preceded for several years by hypereosinophilic syndrome]. (1990) (19)
- Macrophage-derived CXCL9 and CXCL11, T-cell skin homing and disease control in mogamulizumab-treated CTCL patients. (2021) (19)
- Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema. (2020) (19)
- Multidisciplinary team meetings in Oncology: first analysis of benefits and evaluation of activity in a Dermatology unit in France. (2010) (19)
- Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French Study Group for Cutaneous Lymphomas. (1999) (19)
- Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study (2018) (19)
- [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review]. (2011) (19)
- MDA5+ Dermatomyositis Is Associated with Stronger Skin Type I Interferon Transcriptomic Signature with Upregulation of IFN-κ Transcript. (2019) (19)
- [Medical activity in a emergency outpatient department dermatology]. (2003) (18)
- Assessment of tyrosinase variants and skin cancer risk in a large cohort of French subjects. (2011) (18)
- Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC. (2021) (18)
- Minimal residual disease in mycosis fungoides follow‐up can be assessed by polymerase chain reaction (2003) (18)
- Duality of Netherton syndrome manifestations and response to ixekizumab. (2020) (18)
- Impaired antigen presentation in toxic epidermal necrolysis. (1993) (18)
- European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 – Part 2 (2020) (18)
- Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults. (2019) (18)
- Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker (2020) (18)
- Immunopathogenesis of cutaneous T-cell lymphomas. (2003) (18)
- Vemurafenib in the French temporary authorization for use metastatic melanoma cohort: a single-centre trial (2014) (18)
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases (2011) (18)
- Atypical linear IgA dermatosis revealing angioimmunoblastic T-cell lymphoma. (2009) (18)
- Photoallergic reaction induced by flutamide. (1991) (17)
- Borrelia burgdorferi and localized scleroderma. (1989) (17)
- Clinical and biological analysis of peripheral T-cell lymphomas: a single institution study. (1992) (17)
- Cutaneous pseudolymphomas: immunophenotypical and immunogenotypical studies. (1989) (16)
- [Hypereosinophilic syndrome with pachyderma preceding lymphoma. Treatment with interferon alpha]. (1991) (16)
- Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19 (2020) (16)
- Functional characterization of an IL-7-dependent CD4(+)CD8alphaalpha(+) Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma. (2000) (16)
- Atypical severe immune-related adverse effects resulting from sequenced immunotherapy in melanoma. (2015) (15)
- Diffuse dermal angiomatosis associated with severe atherosclerosis: two cases and review of the literature (2015) (15)
- A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs (2017) (15)
- Anti-CCR4 Monoclonal Antibody, Mogamulizumab, Demonstrates Significant Improvement in PFS Compared to Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL): Results from the Phase III MAVORIC Study (2017) (15)
- T-cell receptor-gamma/delta bearing lymphocytes in normal and inflammatory human skin. (1990) (15)
- HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology. (2014) (15)
- Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study (2018) (15)
- Sézary syndrome without erythroderma. (2015) (15)
- Increased severity and epidermal alterations in persistent versus evanescent skin lesions in adult‐onset Still disease (2018) (15)
- Differences in Epstein-Barr virus expression between primary and secondary cutaneous angiocentric lymphomas. French Study Group of Cutaneous Lymphomas. (1998) (15)
- Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Series of 37 Cases and Systematic Review of the Literature. (2018) (14)
- Dermatopulmonary Syndrome Associated With Anti-MDA5 Antibodies After Allogeneic Hematopoietic Stem Cell Transplantation (2017) (14)
- [Intravascular large cell lymphoma revealed by diffuse telangiectasia and cauda equina syndrome]. (2002) (14)
- New Targeted Treatments for Cutaneous T-cell Lymphomas (2017) (14)
- Efficacy and safety of brentuximab vedotin plus bendamustine in advanced‐stage primary cutaneous T‐cell lymphomas (2019) (14)
- Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience (2021) (14)
- CD101 is expressed by skin dendritic cells. Role in T-lymphocyte activation. (1997) (14)
- Emergence of Difficult-to-Treat Tinea Corporis Caused by Trichophyton mentagrophytes Complex Isolates, Paris, France (2022) (14)
- ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells. (2020) (14)
- Angiosarcoma in patients with xeroderma pigmentosum: less aggressive and not so rare? (2013) (14)
- Management of primary cutaneous lymphoma patients during COVID‐19 pandemic: EORTC CLTF guidelines (2020) (14)
- Human and mouse mast cells express and secrete the GPI-anchored isoform of CD160. (2011) (14)
- Human epidermal cells are more potent than peripheral blood mononuclear cells for the detection of weak allogeneic or virus-specific primary responses in vitro. (1985) (14)
- Sezary syndrome cells unlike normal circulating T lymphocytes fail to migrate following engagement of NT1 receptor. (2004) (14)
- Association of porphyria cutanea tarda and lichen planus in a patient with chronic hepatitis C virus infection (1995) (14)
- Cutaneous granulomas during infliximab therapy for spondyloarthropathy. (2008) (14)
- Dramatic response to brentuximab vedotin in refractory nontransformed CD30– mycosis fungoides allowing allogeneic stem cell transplant and long‐term complete remission (2019) (14)
- Non‐invasive short‐term assessment of retinoids effects on human skin in vivo using multiphoton microscopy (2015) (13)
- Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group (2015) (13)
- [Multifocal cutaneous leishmaniasis due to Leishmania infantum under adalimumab therapy]. (2009) (13)
- Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients (2020) (13)
- The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma (2020) (13)
- KIR3DL2/CpG ODN interaction mediates Sézary syndrome malignant T cell apoptosis. (2015) (13)
- Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell‐based immunotherapy (2003) (13)
- Next generation sequencing in myeloid neoplasm-associated Sweet's syndrome demonstrates clonal relation between malignant cells and skin-infiltrating neutrophils. (2020) (13)
- T-Plastin Expression Downstream to the Calcineurin/NFAT Pathway Is Involved in Keratinocyte Migration (2014) (12)
- Lymph node image‐guided core‐needle biopsy for cutaneous T‐cell lymphoma staging (2016) (12)
- Isolation of a CD8αα+ CD4– tumour T‐cell clone with cytotoxic activity from a CD4+ CD8– cutaneous T‐cell lymphoma (2003) (12)
- Immunosuppressive therapy in dermatology and PML (2009) (12)
- [Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation]. (2011) (12)
- Additive effects of calcipotriol and cyclosporine A: from in vitro experiments to in vivo applications in the treatment of severe psoriasis. (1994) (12)
- Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes (2016) (12)
- Active and passive anticytokine immune therapies: current status and development. (2012) (12)
- [Sclerodermatous changes in porphyria cutanea tarda: six cases]. (2013) (12)
- Treatment of cutaneous T-cell lymphoma by retinoids and calcitriol (1995) (12)
- HIV-Related CD8+ Cutaneous Pseudolymphoma: Efficacy of Methotrexate (2013) (12)
- Successful Treatment of Generalized Eruptive Keratoacanthoma of Grzybowski with Acitretin (2019) (12)
- Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA–IIA Mycosis Fungoides (2021) (12)
- First case of chancroid in 14 years at the largest STI clinic in Paris, France (2016) (11)
- Polymorphic expression of CD158k/p140/KIR3DL2 in Sézary patients. (2003) (11)
- Utility of anaerobic bottles for the diagnosis of bloodstream infections (2020) (11)
- Deficient regulatory B cells in human chronic graft-versus-host disease (2015) (11)
- Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain‐like lesion during the COVID‐19 pandemic (2021) (11)
- Cutis laxa associated with monoclonal gammopathy: 14 new cases and review of the literature (2018) (11)
- Antigen‐presenting properties of human epidermal cells compared with peripheral blood mononuclear cells (1985) (11)
- Human orf complicated by epidermolysis bullosa acquisita (2018) (11)
- Functional inhibitory receptors expressed by a cutaneous T cell lymphoma-specific cytolytic clonal T cell population. (2000) (11)
- Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas (2020) (11)
- Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T‐lymphocyte subset in normal and mycosis fungoides skin (2014) (11)
- The evolving field of Dermato‐oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV–UEMS and EORTC Cutaneous Lymphoma Task Force (2020) (11)
- [Acute mast cell leukemia disclosed by vasomotor flushing]. (1997) (11)
- Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma. (2020) (11)
- Neutrophilic Dermatoses Associated with Myeloid Malignancies (2019) (11)
- Acral erythema and systemic toxicity related to CHA induction therapy in acute myeloid leukemia. (1989) (10)
- Actinic cheilitis: a systematic review of treatment options (2020) (10)
- BORRELIA BURGDORFERI AND SHULMAN SYNDROME (1987) (10)
- [Pilotropic T-cell lymphoma without mucinosis: 5 new cases]. (1999) (10)
- Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management (2021) (10)
- Central nervous system involvement of primary cutaneous diffuse large B‐cell lymphoma, leg type: 13 cases (2017) (10)
- Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians (2014) (10)
- APRIL levels are associated with disease activity in human chronic graft-versus-host disease (2016) (10)
- Cetuximab as first-line monotherapy in patients with unresectable squamous cell carcinoma of the skin: Preliminary results of a phase II multicenter study (2008) (10)
- IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma (2018) (10)
- Inter‐observer concordance for the recognition of angiotropism in human melanoma (2011) (10)
- Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. (2019) (10)
- [Teledermatology in a prison setting: A retrospective study of 500 expert opinions]. (2016) (9)
- TH cell diversity and response to dupilumab in patients with atopic dermatitis (2020) (9)
- Evidence of Th1, Th17 and Tc17 cells in psoriasiform chronic graft‐versus‐host disease (2016) (9)
- Focal necrotizing myopathy with ‘dropped-head syndrome’ induced by cobimetinib in metastatic melanoma (2017) (9)
- Study of the reactive dendritic cells in small B-cell lymphoproliferations of the skin (2007) (9)
- Clinical Spectrum, Quality of Life, BRAF Mutation Status and Treatment of Skin Involvement in Adult Langerhans Cell Histiocytosis. (2017) (9)
- In vivo multiphoton imaging for non‐invasive time course assessment of retinoids effects on human skin (2020) (9)
- Dominance of an UBA1 mutant clone over a CALR mutant clone: from essential thrombocytemia to VEXAS (2021) (9)
- A human autoreactive T cell line specific for minor histocompatibility antigen(s) isolated from a bone marrow-grafted patient. (1986) (9)
- CD4+ CD56+ blastic tumor cells express CD101 molecules. (2005) (9)
- Chronic Pain in Patients with Skin Disorders. (2017) (9)
- Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms. (2006) (9)
- Efficacy of dupilumab for controlling severe atopic dermatitis with dominant‐negative CARD11 variant (2021) (8)
- First-in-Human, Multicenter Phase I Study of IPH4102, First-in-Class Humanized Anti-KIR3DL2 Monoclonal Antibody, in Relapsed/Refractory Cutaneous T-Cell Lymphomas: Preliminary Safety, Exploratory and Clinical Activity Results (2016) (8)
- Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016. (2018) (8)
- Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma (2021) (8)
- [Per os desensitization in nickel contact eczema: a double-blind placebo-controlled clinico-biological study]. (1999) (8)
- [Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]. (2010) (8)
- [Immunopathology of psoriasis: from bench to bedside]. (2016) (8)
- Follow-up of patients with complete remission of locally advanced basal cell carcinoma treated with vismodegib after treatment discontinuation: A retrospective multicentric French study. (2017) (8)
- [Cutaneous revelation of Rosai-Dorfman disease: 7 cases]. (2013) (8)
- Striking leflunomide efficacy against refractory cutaneous sarcoidosis. (2014) (8)
- Diagnosis and Treatment of Primary Cutaneous B-Cell Lymphomas: State of the Art and Perspectives (2020) (8)
- [Cutaneous CD8+ epidermotropic cytotoxic T-cell lymphoma with aggressive course]. (2006) (8)
- Kaposi's Sarcoma and Pregnancy: Case Report and Literature Review (2013) (8)
- Developments in the understanding of blood involvement and stage in mycosis fungoides/Sezary syndrome. (2018) (8)
- The value of five blood markers in differentiating mycosis fungoides and Sézary syndrome: a validation cohort * (2020) (8)
- IL-10 Producing Regulatory B cells: Where Are We? (2014) (8)
- Persistent deficiency of mucosal-associated invariant T cells during dermatomyositis. (2019) (8)
- Skin ulcers related to chronic graft‐versus‐host disease: clinical findings and associated morbidity (2014) (8)
- Effectiveness of brentuximab vedotin before and after allogeneic stem‐cell transplantation in the management of transformed mycosis fungoides (2019) (8)
- Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study * (2021) (8)
- Phase I Study of IPH4102, Anti‐KIR3DL2 Mab, in Relapsed/Refractory Cutaneous T‐Cell Lymphomas (CTCL): Dose‐escalation Safety, Biomarker and Clinical Activity Results (2017) (8)
- T-cell receptor and immunoglobulin gene rearrangements in cutaneous T-cell-rich pseudolymphomas. (1991) (8)
- Expression of Sézary Biomarkers in the Blood of Erythrodermic Mycosis Fungoides Patients. (2015) (8)
- EORTC 21012: Phase II Multicentre Study of Caelyx™ Monotherapy In Patients with Advanced Mycosis Fungoides Stage IIb, Iva and IVb with or without Previous Chemotherapy. (2010) (8)
- Post-exposure prophylaxis for HIV infection (2000) (8)
- Mogamulizumab-induced vitiligo in patients with Sézary syndrome: three cases (2021) (8)
- Expression of Sézary Biomarkers in the Blood of Patients with Erythrodermic Mycosis Fungoides. (2016) (8)
- Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients (2017) (8)
- [Pseudolymphoma induced by cyclosporin]. (1989) (8)
- Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation. (2013) (8)
- Nonepidermotropic cutaneous lymphomas. A histopathological and immunohistological study of 52 cases. (1994) (8)
- Gene analysis in 18 cases of cutaneous lymphoid infiltrates of uncertain significance. (1995) (8)
- Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients (2017) (8)
- Delayed hypersensitivity in drug-induced toxic epidermal necrolysis. (1984) (8)
- Livedoid and necrotic skin lesions due to intra-arterial buprenorphine injections evidenced by maltese cross-shaped histologic bodies. (2010) (8)
- KH 1060 for the treatment of lichen planus: a multicenter, randomized, double-blind, vehicle-controlled study. (2000) (7)
- Involvement of the CD39/CD73/adenosine pathway on T cell proliferation and NK cell-mediated ADCC in Sézary syndrome. (2022) (7)
- [Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group]. (2010) (7)
- Characterization and Outcomes in Patients with Mogamulizumab-Associated Skin Reactions in the MAVORIC Trial (2020) (7)
- Lymphomatoid papulosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: three cases (2018) (7)
- Tumor necrosis factor‐&agr; inhibitors for the treatment of pyoderma gangrenosum not associated with inflammatory bowel diseases: A multicenter retrospective study (2019) (7)
- Septic facial vein thrombosis due to Panton-Valentine leukocidin-positive Staphylococcus aureus. (2009) (7)
- Acute myeloid leukemia and myelodysplastic syndrome-associated Sweet's syndrome: a comparative multicentric retrospective study of 39 patients. (2020) (7)
- Sneddon Syndrome revealing dysfibrinogenemia (2003) (7)
- Efficacy of Vinblastine in Primary Cutaneous Anaplastic Large Cell Lymphoma. (2015) (7)
- [Amicrobial pustulosis and systemic lupus erythematosus]. (1991) (7)
- [Granuloma with lymphocytic hyperplasia following vaccination: 10 cases. Presence of aluminium in the biopsies]. (2004) (7)
- Necrobiosis lipoidica with bone involvement successfully treated with infliximab. (2019) (7)
- Trem‐1 is not crucial in psoriasiform imiquimod‐induced skin inflammation in mice (2016) (7)
- Cutaneous tumor lysis syndrome in a patient with HTLV-1 adult T-cell lymphoma/leukemia. (2009) (7)
- Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients (2014) (7)
- Lymphogranuloma Venereum-Serovar L2b Presenting With Painful Genital Ulceration: An Emerging Clinical Presentation? (2017) (7)
- Impaired antigen presentation in toxic epidermal necrolysis (1993) (7)
- Mogamulizumab induces long‐term immune restoration and reshapes tumour heterogeneity in Sézary syndrome * (2022) (7)
- Stabilization of multiple metastatic epithelioid sarcoma under treatment with sunitinib malate (2013) (7)
- RECONSTITUTION OF CYTOTOXIC T LYMPHOCYTE ACTIVITY: Following Allogeneic Bone Marrow Transplantation In Man (1987) (7)
- Outcomes of radiation therapy of indolent cutaneous B‐cell lymphomas and literature review (2018) (7)
- Cutaneous necrosis induced by injection of hydrocarbons. (1992) (7)
- Sebaceous Carcinomas of the Skin: 24 Cases and a Literature Review. (2017) (7)
- Clinical presentation, therapeutic approach and outcome of primary cutaneous marginal zone B‐cell lymphoma presenting as AL amyloidoma of the skin (2019) (7)
- [Penile squamous hyperplasia]. (2018) (6)
- Updates in cutaneous lymphoma: evidence‐based guidelines for the management of cutaneous lymphoma 2018 (2019) (6)
- Treatment of Generalized Deep Morphea With Everolimus. (2016) (6)
- Darier's sign in cutaneous large T-cell lymphoma. (1996) (6)
- T helper cell diversity and response to Dupilumab in atopic dermatitis patients. (2020) (6)
- Efficacy of eculizumab against Eosinophilic Fasciitis associated with Paroxysmal Nocturnal Haemoglobinuria (2017) (6)
- [Ecthyma gangrenosum associated with infection involving a methicillin-sensitive, Panton-Valentine-negative strain of Staphylococcus aureus]. (2015) (6)
- Visceral leishmaniasis in patients with lymphoma (2020) (6)
- Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial (2018) (6)
- [Disseminated herpes triggered by isotretinoin in an atopic patient]. (1990) (6)
- [Lymphoma with skin manifestations in HIV infection: 8 cases]. (1995) (6)
- Pulmonary cryptococcoma in a patient with Sézary syndrome treated with alemtuzumab. (2011) (6)
- [Severe necrotizing myopathy subsequent to Merkel cell carcinoma]. (2011) (6)
- Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome. (2017) (6)
- [Hypocomplementemic urticarial vasculitis]. (2018) (6)
- Low cardiovascular risk and poor quality of life associated with tobacco use and skin infections in adult atopic dermatitis: result of a French multicenter study (2019) (6)
- Identification of clonal skin myeloid cells by next‐generation sequencing in myelodysplasia cutis (2020) (6)
- Grover's disease in a renal transplant patient, after hemodialysis renewal. (2012) (6)
- Introduction: cutaneous T-cell lymphoma (CTCL)--classification, staging, and treatment options. (2008) (6)
- Jessner-Kanof lesion and Borrelia infection. (1990) (6)
- Interleukin 7 receptor expression in cutaneous T-cell lymphomas (1994) (6)
- Disseminated skin involvement in HIV‐associated Burkitt lymphoma: a rare clinical feature with poor prognosis (2016) (6)
- KIR3DL2 expression in patients with adult T‐cell lymphoma/leukaemia (2018) (6)
- [Systemic capillary leak syndrome disclosing mixed diffuse T lymphoma]. (1991) (6)
- High-risk behaviour (2000) (6)
- Efficacy of Mogamulizumab By Prior Systemic Therapy in Patients with Previously Treated Cutaneous T-Cell Lymphoma: Post Hoc Analysis from the Phase 3 Mavoric Study (2018) (6)
- Relapse of severe forms of adult morphea after oral corticosteroid treatment (2013) (6)
- Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas (2020) (6)
- Increased expression of PD1 and CD39 on CD3+CD4+ skin T cells in the elderly (2019) (6)
- Cytokine levels in persistent skin lesions of adult‐onset Still disease (2018) (6)
- [Severe tularaemia mimicking glandular tuberculosis during adalimumab therapy]. (2009) (5)
- Trichosporon inkin causing invasive infection with multiple skin abscesses in a renal transplant patient successfully treated with voriconazole (2017) (5)
- Osteopenia and fractures associated with long-term therapy with MEK inhibitors (2018) (5)
- Detection of a second outbreak of chilblain‐like lesions during COVID‐19 pandemic through teledermatology (2021) (5)
- Mogamulizumab-induced Mucocutaneous Lichenoid Reaction: A Case Report and Short Review (2020) (5)
- Haemophilus parainfluenzae-related cellulitis of the penis following tearing of a short frenulum. (2020) (5)
- TRANSPLANTATION CD24 hi CD27 1 and plasmablast-like regulatory B cells in human chronic graft-versus-host disease (2015) (5)
- [Acute linear IgA bullous dermatosis with circulating IgA monoclonal antibody associated with Hodgkin's disease]. (2010) (5)
- Engagement of IL-1 receptor accessory protein (IL-1RAcP) with the monoclonal antibody AY19 provides co-activating signals and prolongs the CD2-induced proliferation of peripheral blood lymphocytes. (2011) (5)
- Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity * (2021) (5)
- Nocardia asteroides septicemia in a pemphigus patient. Successful treatment with trimethoprim-sulfamethoxazole and amikacin association. (1990) (5)
- Necrotizing cellulitis with multiple abscesses on the leg caused by Serratia marcescens. (2016) (5)
- Unresectable perineal cuniculatum carcinoma: partial remission using systemic isotretinoin and interferon-α2a therapy. (2014) (5)
- [Neutrophilic sebaceous adenitis in a woman]. (2013) (5)
- [Male genital Buschke-Löwenstein tumour]. (2016) (5)
- [Follicular mucinosis. A dermatologic disorder frequently associated with T-cell lymphoma]. (1993) (5)
- Genetic variation at KIT locus may predispose to melanoma (2013) (5)
- Folliculotropic mycosis fungoides is a heterogenous group (2017) (5)
- Sweet syndrome revealing microscopic polyangiitis. (2012) (5)
- Apoptotic and necroptotic cell death in cutaneous inflammation. (2013) (5)
- Phase 2 Multicenter Trial of Oral Quisinostat, a Histone Deacetylase Inhibitor, in Patients with Previously Treated Stage IB-IVA Cutaneous T-Cell Lymphoma (2012) (5)
- Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROCLIPI international Study. (2020) (5)
- Linear immunoglobulin‐A bullous dermatosis complicating multi‐organ tuberculosis at early‐stage treatment (2013) (5)
- Time to next treatment in patients with previously treated cutaneous T-cell lymphoma (CTCL) receiving mogamulizumab or vorinostat: A MAVORIC post-hoc analysis. (2019) (5)
- Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management (2022) (5)
- Thalidomide decreases the production of GM-CSF and TNF-α in the mixed epidermal cell-lymphocyte reaction (1996) (5)
- Letter to the editor with regard to the article entitled “Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping” (2020) (4)
- 459 Anti-CCR4 monoclonal antibody, mogamulizumab (Moga), demonstrates superior efficacy compared to vorinostat (Vor) in patients with previously treated cutaneous T-cell lymphoma (CTCL): results of the phase 3 MAVORIC study (2018) (4)
- B cells from leukemic patients are relatively resistant to in-vitro EBV transformation. (1986) (4)
- [Interstitial mycosis fungoid: a rare variant of mycosis fungoids. Two cases]. (2011) (4)
- Isolation of Tumor-Specific Cytotoxic CD 4 1 and CD 4 1 CD 8 dim 1 T-Cell Clones Infiltrating a Cutaneous T-Cell Lymphoma (1998) (4)
- Primary cutaneous peripheral T‐cell lymphomas with a T‐follicular helper phenotype: an integrative clinical, pathological and molecular case series study (2022) (4)
- Vasculitis and IgA monoclonal gammopathy of cutaneous significance (2018) (4)
- Lymphocytic infiltrates of the skin in association with cyclosporine therapy. (1992) (4)
- Analysis of T‐cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain‐like lesions during the COVID‐19 pandemic (2021) (4)
- Treatment of Sézary syndrome with bexarotene after IFNalpha and methotrexate failure. (2008) (4)
- [Successful treatment of haemodialysis-related porphyria cutanea tarda with deferoxamine]. (2003) (4)
- 18F-fluorodeoxyglucose-positron emission tomography is more sensitive than computed tomography in initial staging of patients with an anaplastic T-cell lymphoma first presenting in the skin (2017) (4)
- Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries (2021) (4)
- [Ulcerated necrobiosis lipoidica: successful treatment with topical tacrolimus and hydroxychloroquine]. (2010) (4)
- [Acquired angioneurotic edema caused by acquired deficiency of C1 esterase inhibitor disclosing lymphoproliferative syndrome. Apropos of a case, review of the literature]. (1982) (4)
- Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study Group (2021) (4)
- [Therapy algorithm for cutaneous T-cell lymphomas]. (2005) (4)
- Infliximab in recalcitrant granuloma annulare (2016) (4)
- A new cause of ‘gloves and socks’ syndrome: chicken pox (2009) (4)
- KIR 3 DL 2 / CpG ODN Interaction Mediates Sézary Syndrome Malignant T Cell Apoptosis (2010) (4)
- Arterial aneurysm with distal ischemia in a renal allografted patient: beware of angiosarcoma. (2013) (4)
- [Erythema nodosum during the course of idiopathic granulomatous mastitis]. (2015) (4)
- Mycoplasma genitalium screening in a specialized French unit: A retrospective study. (2022) (3)
- [KIR3DL2: a new step for the management of patients with Sezary syndrome]. (2006) (3)
- Retinoids 10 Years On (1990) (3)
- Promoter Hypomethylation and Expression of PLS3 in Human Sezary Lymphoma Cells (2013) (3)
- [Gastric sarcoidosis revealed by cutaneous follicular sarcoidosis]. (2011) (3)
- Reconstructed human epidermis: absence of Langerhans cells and failure to stimulate allogeneic lymphocytes in vitro. (1988) (3)
- Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy (2013) (3)
- Lymphomes cutanés : apport de la classification Organisation mondiale de la santé (OMS)-European Organization for research and Treatment of Cancer (EORTC) (2006) (3)
- Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study (2019) (3)
- Plantar keloids: diagnostic and therapeutic issues in six patients (2015) (3)
- Possible pathogenic role of the transmembrane isoform of CD160 NK lymphocyte receptor in paroxysmal nocturnal hemoglobinuria. (2012) (3)
- Male genital lichen planus: A retrospective study of 89 cases. (2021) (3)
- Koebner Phenomenon in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss). (2017) (3)
- Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial (2019) (3)
- TIME TO NEXT TREATMENT IN PATIENTS WITH PREVIOUSLY TREATED CUTANEOUS T‐CELL LYMPHOMA (CTCL) RECEIVING MOGAMULIZUMAB OR VORINOSTAT: A POST‐HOC ANALYSIS OF THE MAVORIC STUDY (2019) (3)
- [Epidermotropic T cell lymphomas as models for tumor progression]. (2006) (3)
- 542 Changes in blood involvement in Sezary syndrome positively correlate with skin severity but not in mycosis fungoides (2018) (3)
- Challenges in the diagnosis of primary cutaneous CD30+ anaplastic large‐cell lymphoma (2019) (3)
- Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides (2022) (3)
- Mixed epidermal cell-lymphocyte reaction in prediction of acute graft-versus-host disease in bone marrow recipients. (1986) (3)
- IPH4102; An Anti-KIR3DL2 Monoclonal Antibody in Refractory Sezary Syndrome: Results from a Multicenter Phase 1 Trial (2018) (3)
- Exploring the role of the skin microenvironment in cutaneous T-cell lymphoma using single cell RNA-sequencing. (2021) (3)
- Validation of a clinical evaluation score for irritative dermatitis: SCOREPI (2013) (3)
- Expansion of circulating CD49b+LAG3+ type 1 regulatory T (Tr1) cells in human chronic graft-versus-host disease. (2020) (3)
- [Infective endocarditis in a dermatology unit]. (2009) (3)
- [Primary cutaneous lymphoma, with the exception of mycosis fungoides]. (1992) (3)
- [CD30 (Ki-1+) anaplastic large cell lymphomas]. (1989) (3)
- Flow cytometry for the assessment of blood tumour burden in cutaneous T‐cell lymphoma: towards a standardized approach (2022) (3)
- NKp46-specific expression on skin-resident CD4(+) lymphocytes in mycosis fungoides and Sézary syndrome. (2014) (3)
- [Treatment of angiolymphoid hyperplasia with eosinophilia (ALHE) using topical tacrolimus: Two cases]. (2015) (3)
- Acquired bullous dermatosis associated with IgA multiple myeloma. (2013) (3)
- Complete remission of sclerodermatous cutaneous graft‐versus‐host disease after low‐dose interleukine‐2 treatment (2020) (3)
- Phase 3 study of anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat in relapsed or refractory cutaneous T-cell lymphoma (CTCL). (2014) (3)
- [Should Ofuji's papuloerythroderma be considered an individual entity?]. (1992) (3)
- [Negativity of Borrelia burgdorferi serology in scleroderma en plaques]. (1989) (3)
- Clinical, Pathological and Molecular Features of Myelodysplasia Cutis. (2021) (3)
- Clinical efficacy of selective JAK1 inhibition and transcriptome analysis of chronic discoid lupus erythematosus (2021) (3)
- Severe hypercalcemia complicating granulomatous slack skin disease: an exceptional case (2019) (3)
- Single-center experience in French Temporary Authorization for Use (TAU) metastatic melanoma program with ipilimumab. (2014) (3)
- Alopecic patches of the scalp: a variant of primary cutaneous follicle centre B‐cell lymphoma reported in a series of 14 cases (2019) (3)
- A FOCUS ON IL-17 TARGETING TREATMENTS IN PSORIASIS (2016) (3)
- CCR8 is a new therapeutic target in cutaneous T-cell lymphomas (2022) (3)
- [New developments in Sézary syndrome]. (2012) (3)
- Pityriasis rubra pilaris with prominent acantholytic dyskeratosis. (2011) (3)
- Nosocomial disseminated Mycobacterium chelonae infection in an immunocompromised patient. (2010) (3)
- IPH4102 in relapsed/refractory cutaneous T cell lymphoma (CTCL): Results of the first-in-human multicenter phase 1 study (2018) (3)
- Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial (2021) (2)
- Outcome And Clinico-Phenotypical Features Of Acute Lymphoblastic Leukemia/Lymphoma With Cutaneous Involvement: A Multicentric Case-Series. (2020) (2)
- Neutrophilic dermatoses. (2022) (2)
- Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study) (2020) (2)
- Diversity and compartmentalization of Human Polyomavirus 7 in a patient with dyskeratotic dermatosis (2020) (2)
- Suspected Viral Maculopapular Eruptions: An Audit of Practice (2013) (2)
- Lymph node and visceral progression without erythroderma or blood worsening in erythrodermic cutaneous T‐cell lymphoma: nine cases (2021) (2)
- [Treatment of HIV facial lipoatrophy with a submalar porous polyethylene implant (Medpor)]. (2009) (2)
- Guideline on Lichen sclerosus (2014) (2)
- Major achievements of the EORTC Cutaneous Lymphoma Task Force (CLTF) (2012) (2)
- EF/SSc overlap syndrome and aplastic anaemia resistant to immunosuppressive therapy. (2012) (2)
- [Hepato-pulmonary Nocardia infections (report of one case) (author's transl)]. (1979) (2)
- [Cutaneous tuberculosis of the ear due to Mycobacterium bovis]. (2016) (2)
- Treatment of mycosis fungoides and Sézary syndrome with romidepsin: a series of 32 cases from the French Study Group for Cutaneous Lymphoma (2018) (2)
- EFFICACY OF MOGAMULIZUMAB IN PREVIOUSLY TREATED PATIENTS WITH LESS ADVANCED MYCOSIS FUNGOIDES: RESULTS FROM THE MAVORIC STUDY (2019) (2)
- Resistances to vismodegibs in a French case series of 207 patients with locally advanced basal cell carcinoma. (2016) (2)
- Pachydermoperiostosis: The value of molecular diagnosis. (2017) (2)
- Sleep disturbance in atopic dermatitis: a case–control study using actigraphy and smartphone‐collected questionnaires (2020) (2)
- [Bilateral elastofibroma dorsi]. (2012) (2)
- Cutaneous chronic graft-vs-host disease and hepatitis C virus. (1995) (2)
- [Complications of tattoos: clinical and pathological classification, pathophysiology, particle kinetics]. (2020) (2)
- Congenital yellow nail syndrome presenting with eyelid lymphedema and fetal hydrops (2019) (2)
- Penoscrotal Paget's disease. (2021) (2)
- [Circumcision-induced penodynia]. (2012) (2)
- Corrigendum: Management of primary cutaneous lymphoma patients during COVID‐19 pandemic: EORTC CLTF guidelines (2020) (2)
- Blue toe syndrome in cutaneous polyarteritis nodosa. (2018) (2)
- [Cutaneous lymphoma of the Sézary and Bouvrain type. Progress in physiopathologic and therapeutic outlook]. (1998) (2)
- Diagnosis and Treatment of Melanoma. European Consensus ⴀbased Interdisciplinary Guideline Developed by the Guideline Subcommittee of the (2012) (2)
- [Sarcoid-like granulomatosis associated with eosinophilic fasciitis]. (2017) (2)
- [Sezary syndrome treated by cytapheresis. Short and long-term results]. (1996) (2)
- [Urticarial vasculitis associated with essential thrombocythaemia progressing to myelofibrosis]. (2014) (2)
- 516 Global collaboration for establishment of a prognostic index in mycosis fungoides & Sezary Syndrome (2018) (2)
- Suppurative keloids: a complication of severe keloid disease (2021) (2)
- Sarcoidosis associated with Kaposi's sarcoma: description of four cases. (2012) (2)
- [The value of biopsy in the diagnosis of penile dermatoses]. (2012) (2)
- P99 Calcipotriol potentiates the immunosuppressive effects of cyclosporin A in allogeneic reactions (1991) (2)
- In vitro evaluation of genetic predisposition to toxic epidermal necrolysis (1993) (2)
- Optic neuritis associated with tumor necrosis factor-alfa antagonists for the treatment of psoriasis. (2012) (2)
- Effect of expression of ICOS in cutaneous T-cell lymphoma and its targeting on killing of malignant cells. (2020) (2)
- Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of Sézary Syndrome Patients. (2019) (2)
- [Erdheim-Chester disease: a form of xanthogranulomatosis]. (1989) (2)
- Image‐guided lymph node core‐needle biopsy predicts survival in mycosis fungoides and Sézary syndrome * (2021) (2)
- [Ainhum and "African acral keratoderma": three cases]. (2015) (2)
- Reactional squamous hyperplasia of the foreskin (2020) (2)
- [Malakoplakia of the submandibular gland in a renal transplant patient]. (2015) (2)
- CD70 EXPRESSION IN CUTANEOUS T CELL LYMPHOMA (CTCL) PATIENTS AND MECHANISMS OF ACTION OF ARGX‐110 IN SKIN: HISTOPATHOLOGICAL AND CLINICAL DATA (2017) (2)
- Donor Lymphocyte Infusion for Primary Cutaneous T Cell Lymphomas: A Study from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the French Study Group on Cutaneous Lymphomas (GFLEC) (2018) (2)
- Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman's disease): a multicenter retrospective study of 119 patients. (2020) (2)
- Chronic graft versus host disease presenting as lichen planus pigmentosus (2018) (2)
- Imported leishmaniasis in travelers: a 7-year retrospective from a Parisian hospital in France (2021) (2)
- Folliculotropic mycosis fungoides associated with GATA2 deficiency: a new skin manifestation (2018) (2)
- Engagement of ILT 2 / CD 85 j in Sézary syndrome cells inhibits their CD 3 / TCR signaling (2002) (2)
- T Cell Receptor Variable Region Gene Expression in Cutaneous T-Cell Lymphoma (1994) (2)
- Epidermodysplasia verruciformis in an adult patient with a germline Interleukin‐2 inducible T‐Cell Kinase mutation and lymphoma: the case of inherited versus acquired (2018) (2)
- Diagnostic performance of high‐throughput sequencing of the T‐cell receptor beta gene for the diagnosis of cutaneous T‐cell lymphoma (2021) (2)
- Catastrophic cryofibrinogenaemia associated with chronic lymphocytic leukaemia and salvage therapy using plasmapheresis and cyclophosphamide (2017) (2)
- Ifosfamide and etoposide in advanced‐stage, relapsed or refractory primary cutaneous T‐cell lymphomas (2020) (1)
- Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness (2018) (1)
- Abstract 3231: Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes effector function (2016) (1)
- Real life data on advanced cutaneous T cell lymphoma patients treated with brentuximab vedotin: results from a multicenter European EORTC study (2019) (1)
- CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas. (2023) (1)
- Cutaneous gamma delta T‐Cell lymphoma with indolent evolution: a series of five cases (2022) (1)
- Practical Events in the Management of a Collodion Baby (2016) (1)
- Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT). (2021) (1)
- [Myeloproliferative hypereosinophilic syndrome revealed by bipolar mucosal ulcerations]. (2011) (1)
- Ultrasound-guided core needle biopsy (US-CNB) of superficial lymph nodes: An alternative to fine-needle aspiration cytology (FNAC) for the diagnosis of lymph node metastasis in melanoma. (2014) (1)
- Folliculotropic CD8+ mycosis fungoides associated with diffuse mucosal involvement (2018) (1)
- Photo-sensitive mycosis fungoides: a new variant? (2017) (1)
- Recent advances on cutaneous lymphoma epidemiology (2022) (1)
- L’érysipèle du pénis et du scrotum (2018) (1)
- Long‐term disease control and safety with the anti‐CCR4 antibody mogamulizumab: Post‐hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T‐cell lymphoma (2022) (1)
- Dramatic response to dupilumab in papular amyloidosis (2022) (1)
- A rare case of disseminated skin and mucosal necrobiotic xanthogranuloma and xanthoma (2017) (1)
- Bone involvement in primary cutaneous diffuse large B-cell lymphoma, leg-type. (2022) (1)
- A multicenter, open label, phase II study to assess the efficacy and safety of APO866 in the treatment of patients with refractory or relapsed cutaneous T-cell lymphoma. (2015) (1)
- PAK1-dependent anti-tumor effect of AAC-11-derived peptides on Sézary syndrome malignant CD4+ T lymphocytes. (2021) (1)
- [Herpes virus infections in immunocompetent children and adults. Varicella and zona]. (2002) (1)
- Sezary's cell (2002) (1)
- [The Gardner-Diamond syndrome or painful recurrent ecchymotic purpura]. (1984) (1)
- [Cutaneous manifestations revealing cryofibrinogenaemia associated with monoclonal gammopathy]. (2013) (1)
- Lupus Erythematosus Tumidus Mimicking Primary Cutaneous Marginal Zone B-cell Lymphoma (2020) (1)
- Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients (2022) (1)
- [Miliary osteoma cutis of the face]. (2020) (1)
- Male sex, discoid lupus erythematosus and lower limb involvement are associated with systemic lupus in lupus panniculitis patients: a multicenter case series of 74 patients. (2021) (1)
- Large‐cell transformation is an independent poor prognostic factor in Sézary syndrome: analysis of 117 cases (2022) (1)
- Paraneoplastic acanthosis nigricans: the first reported case associated with Sézary syndrome (2016) (1)
- Natural killer reprogramming in cutaneous T-cell lymphomas: Facts and hypotheses (2013) (1)
- Induction of rat CD4+ proliferative and mouse CD8+ cytotoxic T-cell lines specific for human papillomavirus type 16 antigens. (1996) (1)
- Prognostic factors in mycosis fungoides: the PROCLIPI study (2019) (1)
- Diffuse lipoatrophic panniculitis: A disfiguring disease (2014) (1)
- Zoon's plasma cell balanitis associated with male genital lichen sclerosus (2020) (1)
- Time to Next Treatment in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL) Receiving Mogamulizumab or Vorinostat: A MAVORIC Post-Hoc Analysis (2019) (1)
- [Two cases of psoas abscesses caused by group A beta-haemolytic streptococcal infection with a cutaneous portal of entry]. (2010) (1)
- Abstracts from the 4th World Congress of the International Dermoscopy Society, April 16–18, 2015, Vienna, Austria (2015) (1)
- The Mixed Epidermal Cell Lymphocyte Reaction Allows the Detection of Alloreactivities Before Graft in HLA Identical Siblings (1985) (1)
- Aberrant expression of CD56 by circulating Sézary syndrome malignant T lymphocytes (2013) (1)
- Lack of evidence that HACE1 is not a tumor suppressor gene in NKTCL: to the editor-in-chief. Authors' reply. (2015) (1)
- Patient Characteristics of Long-Term Responders to Mogamulizumab: Results from the MAVORIC Study (2020) (1)
- Review for "Critical concepts and management recommendations for cutaneous T-cell lymphoma: A consensus-based position paper from the Italian Group of Cutaneous Lymphoma" (2020) (1)
- RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morphea (2022) (1)
- Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas (2013) (1)
- Clinical characteristics of Mycosis fungoides palmaris et plantaris: two cases and a systematic literature review (2021) (1)
- Patient characteristics of long-term responders to mogamulizumab: results from the MAVORIC study. (2021) (1)
- Chronic oral lichenoid erosions revealing haematological malignancies (2018) (1)
- Sublethal radionecrosis after prolonged radioscopy: multiple systems issues in interventional cardiology (2014) (1)
- [Urogenital emergencies in dermatology]. (2019) (1)
- Necrobiosis Lipoidica Mimicking Cutaneous Sarcoidosis Finally Treated With an Intralesional Injection of Corticosteroid: A Case Report (2020) (1)
- Functional role of CD101 on skin dendritic cells. (1997) (1)
- Increased CD8+CD28- circulating T cells and high blood interferon score characterize the systemic inflammation of amyopathic dermatomyositis. (2019) (1)
- [Monoclonal antibodies targeting IL-17A or its receptor in psoriasis: a new therapeutic approach?]. (2012) (1)
- Mogamulizumab‐induced granulomatous dermatitis of the scalp: a distinct entity associated with clinical response (2022) (1)
- [Development of targeted treatments for cutaneous T cell lymphomas]. (2012) (1)
- Uncommon presentation of pigmented paraungual basal cell carcinoma on the first toe treated with total excision (2020) (1)
- Hypothyroidism revealed by acquired ichthyosis in an adult patient. (2021) (1)
- Mycosis fungoides presenting as vulvar plaques (2019) (1)
- Panniculite lupique de diagnostic difficile (2011) (1)
- Efficacy of mogamulizumab in previously treated patients with less advanced mycosis fungoides (MF): results from the MAVORIC study (2019) (1)
- [Pustular psoriasis localized to the genital region]. (2013) (1)
- Guideline on Photodynamic Therapy (2014) (1)
- [Necrotic leg ulcers after topical application of chlormethine]. (2019) (1)
- Is mogamulizumab-induced alopecia areata associated with favorable outcomes in Sézary syndrome? (2021) (1)
- [Association of borderline tuberculoid leprosy and tuberculosis: A case report and review of the literature]. (2020) (1)
- [Progress in the diagnosis and physiopathology of cutaneous lymphoma]. (1993) (1)
- [Contribution of immunotherapy to the treatment of T-cell lymphoma of the skin]. (1999) (1)
- Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study (2023) (1)
- LACUTAMAB IN PATIENTS (PTS) WITH ADVANCED MYCOSIS FUNGOIDES (MF) ACCORDING TO KIR3DL2 EXPRESSION: EARLY RESULTS FROM THE TELLOMAK PHASE 2 TRIAL (2021) (1)
- Granulomatous slack skin T-cell lymphoma: an important differential diagnosis with giant cell tumor of soft tissue* (2015) (1)
- Long-Term Clinical Benefit to Anti-CCR4 Mogamulizumab: Results from the Phase 3 Mavoric Study in Previously Treated Cutaneous T-Cell Lymphoma (CTCL) (2018) (1)
- Granulomatous rash associated with mogamulizumab mimicking mycosis fungoides: a case series. (2021) (1)
- Vasculitis Mimicking Pseudo Erysipelas in Systemic Lupus Erythematosus. (2019) (1)
- Bone marrow leukaemic transformation of myelodysplastic syndrome revealed by a cutaneous Langerhans cell infiltrate: partial response to azacitidine. (2013) (1)
- Respiratory distress with radiographic pleural effusion during measles virus infection (2010) (1)
- [HPV-induced penile intra-epithelial neoplasia: Bowenoid papulosis]. (2017) (1)
- Granulomatous slack skin: clinical characteristics, prognosis and response to therapy. A study from the Cutaneous Lymphoma French Study Group (2022) (1)
- Time-to-next-treatment and time-to-next-systemic treatment in patients included in the PROCLIPI registry (2021) (0)
- [Management of pain]. (2000) (0)
- Cervicofacial actinomycosis. (2012) (0)
- [Wells' cellulitis and bacterial necrotizing cellulitis induced by anakinra]. (2008) (0)
- Infective dermatitis‐like lesions as a novel skin manifestation of systemic lupus erythematosus (2019) (0)
- PS1260 EFFICACY OF MOGAMULIZUMAB IN PREVIOUSLY TREATED PATIENTS WITH LESS ADVANCED MYCOSIS FUNGOIDES: RESULTS FROM THE MAVORIC STUDY (2019) (0)
- Neutrophilic Urticaria with Systemic Inflammation Associated with Immunoglobulin A Myeloma (2021) (0)
- Skin involvement in angioimmunoblastic lymphadenopathy: A clinical immunohistochemical and molecular analysis (1998) (0)
- Induction of rat proliferative CD8+ T-cell lines specific for human papillomavirus type 16 E6 and E7 proteins (1994) (0)
- [Is scleroderma an allo-immune disease?]. (1999) (0)
- ILDS Newsletter No. 28 (2013) (0)
- Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome. (2023) (0)
- immunoglobulin-like receptor killer cell - CD4+ cutaneous T-cell lymphoma cells express the p140 (2013) (0)
- Efficacy of mogamulizumab in previously treated patients with less advanced mycosis fungoides: Results from the MAVORIC study. (2019) (0)
- An agent for diagnosis and treatment of CTCL (2001) (0)
- Reply to: "The relationship between lymphocytic thrombophilic arteritis and cutaneous polyarteritis nodosa". (2016) (0)
- Eczema/prurigo as an unusual presentation of Kimura's disease. (2021) (0)
- Defining B2 involvement in Sezary syndrome results from the PROCLIPI study (2019) (0)
- [Gingival hypertrophy disclosing sarcoidosis]. (1991) (0)
- Update of the Guideline on Chronic Urticaria (2014) (0)
- Characterization of CD39 expression in cutaneous T cell lymphomas (2022) (0)
- 042 MDA5+ dermatomyositis is associated with stronger skin type I interferon transcriptomic signature with up-regulation of IFN-κ transcript (2019) (0)
- Immunothérapie ciblée des lymphomes T cutanés par IPH4102, un anticorps monoclonal « first-in-class » dirigé contre la molécule KIR3DL2 : étude de phase I internationale multicentrique (2018) (0)
- [Metastatic extramammary Paget's disease of the scrotum]. (2012) (0)
- Large cell transformation is an independent prognostic factor in Sézary syndrome: a retrospective analysis of 117 cases. (2021) (0)
- Granulomatous slack skin: clinical retrospective study of 8 cases of the Cutaneous Lymphoma French Study Group. (2021) (0)
- Common and uncommon types of cutaneous T-cell lymphoma (1998) (0)
- Methotrexate as a corticosteroid-sparing agent in leprosy reactions: A French multicenter retrospective study (2023) (0)
- Modulation of NK cell activation by exogenous calcium from alginate dressings in vitro (2023) (0)
- Vemurafenib as a neoadjuvant therapy in advanced melanoma: local tumour control, but no prevention of metastatic relapse. (2013) (0)
- Cutaneous T-cell Infiltrates : Analysis of T-cell Receptor y Gene Rearrangement by Polymerase Chain Reaction and Denaturing Gradient Gel Electrophoresis (2002) (0)
- recommendations for the management of cutaneous B-cell lymphomas International Society for Cutaneous Lymphoma consensus European Organization for Research and Treatment of Cancer and (2008) (0)
- Revisiting blood classification in Mycosis Fungoides and Sézary syndrome with the KIR3DL2 marker (2018) (0)
- Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial. (2021) (0)
- 884 Treatment of Netherton syndrome patients with Ixekizumab: A case series (2020) (0)
- Lichen planus associated with eosinophilic fasciitis outside the setting of chronic graft-versus-host disease. (2022) (0)
- Mycosis Fungoides: A differential diagnosis to consider for lichenoid keratosis (2023) (0)
- [M. Bagot, N. Terki, S. Bacha, D. Moyse, C. Suck, J. Revuz: "Per os desensitization in nickel contact eczema: a double-blind placebo-controlled clinico-biological study. 1999]. (2000) (0)
- Asymetric red-blue hypertrophic hand and tenosynovitis due to acrodermatitis chronica atrophicans. (2018) (0)
- 023 RNA sequencing of chronic GVHD skin lesions identifies TREM1 as a possible therapeutic traget in lichen planus (2021) (0)
- Plain language summaries in Simplified Chinese (2016) (0)
- [Update on regulatory B cells]. (2014) (0)
- Progression-Free Survival and Overall Survival Among a Patient Cohort of Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom (2019) (0)
- [Misleading and rare form of vulvar carcinoma with fast development. Suspicion of human papillomavirus infection]. (1990) (0)
- Image Gallery: Juvenile cutaneous chronic graft‐versus‐host disease presenting as bullous pemphigoid (2017) (0)
- Conflicts of interests 2 The Work Under Consideration for Publication (2014) (0)
- Case 41. Cutaneous Epstein–Barr Virus post-transplant lymphoproliferative disorder (2021) (0)
- Cutaneous manifestations of lymphoid‐variant hypereosinophilic syndrome (2022) (0)
- 040 Pathogenicity of anti-desmoglein3 IgA1 autoantibodies is Fc-dependentin IgA pemphigus (2019) (0)
- 431 APRIL levels are associated with disease activity in human chronic graft versus host disease (2016) (0)
- 416 Co-encapsulation of Immuno-active And Anti-inflammatory Molecules in a Pickering Emulsion for Inflammatory Dermatoses Therapeutic Approach (2019) (0)
- Guideline on Lichen sclerosus Developed by the Guideline (2014) (0)
- Exploring the non-lymphocytic cutaneous microenvironment in advanced cutaneous T-cell lymphomas using single-cell RNA-sequencing. (2023) (0)
- 091 IPH4102 (an anti-KIR3DL2 antibody) in refractory cutaneous T cell lymphoma (2019) (0)
- Slow acetylator genotype as a metabolic predisposition to sulfonamide-induced toxic epidermal necrolysis (1994) (0)
- Gene expression profiling of human angiotropic primary melanoma (2010) (0)
- Lymph node imaging in patch/plaque mycosis fungoides; enlarged LN are infrequent but lymphomatous nodal involvement may occur and upstage patients to advanced disease (2018) (0)
- 380 Innovative Coencapsulation of Immunoactive and Anti-inflammatory Drugs for Treating Inflammatory Dermatoses (2022) (0)
- Meeting of the Belgian Royal Society for Dermatology and Syphiligraphy (1992) (0)
- [Male median raphe]. (2015) (0)
- Epidemiological and serological characteristics of patients with late syphilis: a retrospective cohort of 76 patients. (2023) (0)
- Cutaneous lymphomas behave worse in patients treated with biologics for psoriasis: a multicenter study (2019) (0)
- Folliculotropic mycosis fungoides presents with two distinct clinicopathological presentations: an international virtual study (2019) (0)
- [Cutaneous lymphomas]. (2009) (0)
- Diagnostic performance of high throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma (2021) (0)
- Cutaneous neonatal lupus: two cases. (2012) (0)
- PSS28 DEVELOPMENT OF AN INSTRUMENT MIRRORING PATIENT AND PHYSICIAN PERCEPTION OF PSORIASIS SEVERITY AND TREATMENT EFFECT (2010) (0)
- Lymphomatoid papulosis types D and E: a multicentric series on 21 patients (2019) (0)
- Evidence for an HTLV-I like infection in HTLV-I seronegative cutaneous lymphomas presenting as hypereosinophilic syndrome (1993) (0)
- Hydroxychloroquine dose tapering or discontinuation in cutaneous lupus erythematosus after remission: a retrospective multicenter cohort study of 56 patients. (2021) (0)
- PS1256 CONTEMPORARY TREATMENT PATTERNS AND RESPONSE IN RELAPSE/REFRACTORY CUTANEOUS T-CELL LYMPHOMA (CTCL) IN CLINICAL PRACTICE IN FRANCE, GERMANY ITALY, SPAIN AND THE UNITED KINGDOM (2019) (0)
- TELLOMAK: T‐CELL LYMPHOMA ANTI‐KIR3DL2 THERAPY: AN OPEN LABEL, MULTI‐COHORT, MULTI‐CENTER, INTERNATIONAL PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF IPH4102 ALONE OR IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH ADVANCED T‐CELL LYMPHOMA (2019) (0)
- Cutaneous T-cell lymphoma. Preface. (2008) (0)
- Pyoderma gangrenosum granulomateux mutilant du pénis. Attention à la pathergie (2017) (0)
- [Infectious cellulitis of the penis and scrotum]. (2018) (0)
- Contents Vol. 222, 2011 (2011) (0)
- Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet’s Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils (2020) (0)
- ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells. (2021) (0)
- ILDS Newsletter No. 30 (2013) (0)
- Treatment of early-phase mycosis fungoides: results from the Prospective Cutaneous Lymphoma International (PROCLIPI) study (2019) (0)
- Specific Marker of Sézary Cells Detection of Extracellular Vimentin as a SC5 mAb Represents a Unique Tool for the (2013) (0)
- [Treatment of epidermotropic lymphoma]. (1988) (0)
- [Cutaneous-mucous allergies in children and adults. Contact eczema]. (2002) (0)
- Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report (2020) (0)
- Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome (2021) (0)
- [A 10 year-old thigh lesion]. (2008) (0)
- 267 Characterization of Cancer-Associated Fibroblasts from Mycosis Fungoides and Sézary syndrome (2021) (0)
- [Psoriatic arthritis]. (2008) (0)
- 516 The diagnostic and prognostic value of five blood markers in cutaneous T-cell lymphomas: a validation cohort (2019) (0)
- [Rash and erythroderma: identify and treat the cause]. (2021) (0)
- against Cutaneous T-cell Lymphoma IPH 4102 , a Humanized KIR 3 DL 2 Antibody with Potent Activity (2014) (0)
- Acknowledgement to Referees for Dermatology 2015 (2015) (0)
- [Dyspnea and ankle erythema in a 71 year-old man]. (2018) (0)
- Jadassohn-Dössekker's atypical tuberous myxedema: report of three cases and review of literature. (2023) (0)
- Contents Vol. 226, 2013 (2013) (0)
- [Authors'response to the letter on the article "Teledermatology in a prison setting: A retrospective study of 500 expert opinions"]. (2017) (0)
- Histopathology of Sèzary syndrome in contrast to other erythrodermic skin diseases. (2013) (0)
- 043 Persistent deficiency of mucosal associated invariant T cells in dermatomyositis (2019) (0)
- [Mixed lympho-epidermal cell cultures: value in bone marrow grafts]. (1989) (0)
- SURVIVAL AMONG A PATIENT COHORT OF RELAPSED/REFRACTORY MYCOSIS FUNGOIDES IN FRANCE, GERMANY, ITALY, SPAIN AND THE UNITED KINGDOM (2019) (0)
- Acropulpitis in systemic lupus erythematosus is associated with high type 1 interferon signature (2021) (0)
- ILDS Newsletter No. 19 (2011) (0)
- [Papules on the back of the hands]. (2010) (0)
- [The mixed lympho-epidermal culture: a predictive test of the graft-versus-host reaction in receivers of bone marrow grafts]. (1988) (0)
- CD 3 / TCR signaling Engagement of ILT 2 / CD 85 j in Sezary syndrome cells inhibits their (2002) (0)
- Cover Image (2020) (0)
- Thymic localization of erythrodermic cutaneous T‐cell lymphoma (2018) (0)
- Treatment of early-stage mycosis fungoides: Results from the PROCLIPI study (2018) (0)
- Cutaneous T-cell lymphoma cells release proapoptotic Fas ligand in lysosomal secretory vesicles (2019) (0)
- Un syndrome de Sézary (2015) (0)
- Perioral skin thickening revealing AL amyloidosis (2022) (0)
- 198 Il-33 is a central mediator of necroptosis-induced skin inflammation (2021) (0)
- [Penile squamous cell carcinoma]. (2020) (0)
- Lacutamab in Patients with Advanced Sezary Syndrome: Results from an Interim Analysis of the Tellomak Phase 2 Trial (2022) (0)
- Immunophenotypic identification and characterization of CTCL tumor cells in blood using standardized flow cytometry: a European multicenter study (2022) (0)
- Cutaneous Biology Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy (2003) (0)
- [Epstein-Barr virus and cutaneous T lymphoma]. (1997) (0)
- 671 Study of the molecular and functional effects of wound dressings on human dermal fibroblasts (2019) (0)
- Clinical aspects and outcome of lymphoblastic leukemia/lymphoma with cutaneous involvement (2019) (0)
- 176 The Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study identifies clinical prognostic markers and establishes the foundation for large-scale translational research in cutaneous lymphoma (2019) (0)
- Mogamulizumab induces long term immune restoration and reshapes tumoral heterogeneity in Sézary syndrome (2021) (0)
- CD8+ disseminated small and medium pleomorphic T-cell lymphoma with blood involvement and secondary hemophagocytic syndrome (2006) (0)
- [Superficial pemphigus: Histological image of neutrophilic spongiosis]. (2017) (0)
- Epidermal cyst formation of the lip following autologous fat transplant (2022) (0)
- [Update on the use of active anti-cytokine therapies with kinoid vaccines for the treatment of inflammatory diseases]. (2013) (0)
- [Impact of algorithms proposed by the Cutaneous Lymphoma French Study Group for diagnosis of cutaneous lymphoproliferations]. (2021) (0)
- [Lumbar puncture: indications and limitations]. (1984) (0)
- Physiopathologie, classification et traitement des lymphomes cutanés Physiopathology, classification and treatment of cutaneous lymphomas (2016) (0)
- Association of Vemurafenib and Pipobroman Enhances BRAF-CRAF Dimerization in Squamous Cell Carcinoma. (2016) (0)
- Granular parakeratosis involving the glans of the penis and foreskin. (2020) (0)
- The diagnostic and prognostic value of five blood markers in cutaneous T-cell lymphomas: a validation cohort (2019) (0)
- PAK1-Dependent Antitumor Effect of AAC-11 ‒ Derived Peptides on Se´zary Syndrome Malignant CD4 D T Lymphocytes (2021) (0)
- T-cell receptor rearrangements in the skin and blood of patients in the PROCLIPI study: detection of clonal rearrangements in the skin (and blood) correlates with the B-class of MF and SS patients (2019) (0)
- [Apparent worsening of psoriasis lesions revealing methotrexate overdosage]. (2017) (0)
- Adenovirus-Interferon-g (TG1042) Demonstates Clinical Activity in Relapsing Primary Cutaneous Lymphoma (PCL): A Phase I/II Multicentric Trial. (2005) (0)
- Abstract 651:Ex vivoandin vivocharacterization of IPH4102, a humanized anti-KIR3DL2 antibody for the treatment of cutaneous T-cell lymphomas (2014) (0)
- [Calciparin hypersensitivity reaction]. (1993) (0)
- [Variability and diagnostic limitations in cutaneous pseudolymphoma]. (2008) (0)
- Myelodysplasia cutis (2020) (0)
- Explorer Aggressive Epidermotropic Cutaneous CD 8 + Lymphoma (0)
- 464 CCR8 is a new therapeutic target in cutaneous T-cell lymphomas (2022) (0)
- Treatment of Early-Stage Mycosis Fungoides With Twice-Weekly Applications of Mechlorethamine and Topical Corticosteroids (2017) (0)
- [Antitumor immune reactions in lymphoma]. (1998) (0)
- Letters to the Editor Sweet syndrome revealing microscopic polyangiitis (2012) (0)
- Intravascular relapse of an extra-nodal NK/T-cell lymphoma, nasal-type, presenting as diffuse and eruptive telangiectasia. (2021) (0)
- Chairman of EDF Guideline Commitee (2006) (0)
- [Palmar and plantar erythematosquamous plaques]. (2006) (0)
- Treatment efficacy for Sézary syndrome: an international, multi-centre, comparative study of current systemic therapies (2021) (0)
- Adenovirus-interferon γ (TG1042) demonstrates good tolerance and efficacy in relapsing primary cutaneous lymphoma (PCL): Final results of a phase I/II multicentric trial. (2006) (0)
- [Eccrine porocarcinoma with Bowenoid changes: a challenging diagnosis of adnexal neoplasm]. (2014) (0)
- Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas (2021) (0)
- First-in-human, open label, multicenter phase I of IPH4102, first-in-class humanized anti-KIR3DL2 monoclonal antibody, in relapsed/refractory cutaneous T-cell lymphomas. (2016) (0)
- Supplementary Barbieux et al (2020) (0)
- Distinction between CTCL and inflammatory dermatoses using mRNA expression of cancer-associated fibroblast markers from skin biopsies (2022) (0)
- Papular mucinosis associated with band acro-osteolysis: a new syndrome associated with connective tissue-disease. (2021) (0)
- Prognostic F actors i n P rimary C utaneous L arge B -Cell Lymphomas: A E uropean M ulticenter S tudy (2001) (0)
- KIR3DL2 expression in patients with adult T-cell lymphoma/leukaemia (ATLL) (2018) (0)
- Contents, Vol. 186, 1993 (1993) (0)
- [Cutaneous plasmacytosis with Darier's sign in a woman of European origin]. (2020) (0)
- Early detection of relapse in Sézary syndrome: the added value of KIR3DL2, T-plastin, Twist and Tox for clinical routine (2022) (0)
- Contents Vol. 231, 2015 (2015) (0)
- The importance of dosage for naltrexone treatment in Hailey-Hailey disease (2022) (0)
- Cutaneous B-cell lymphoma and benign cutaneous hyperplasia associated with anetoderma (2001) (0)
- Managing the CD30+lymphoproliferative diseases (2010) (0)
- Long-term complete remission induced by mogamulizumab in a severe Sezary patient, together with five different possible auto-immune manifestations (2018) (0)
- [Epitheliotropic lymphomas: better identification for improved treatment]. (2010) (0)
- [Differentiated penile intra-epithelial neoplasia]. (2017) (0)
- Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome. A multicentre, retrospective, real-world French study. (2023) (0)
- [Sarcoidal alopecia]. (2020) (0)
- Expansion of Circulating CD49bLAG3 Type 1 Regulatory T Cells in Human Chronic Graft-Versus-Host Disease (2020) (0)
- [Polymorphism and differential diagnosis of neonatal lupus erythematosus]. (2020) (0)
- "African" acral keratoderma: Further evidence for a single entity. A retrospective study of 42 patients. (2022) (0)
- Abstracts presented at the 48th Annual Meeting of the American Society of Dermatopathology October 20–23, 2011 Seattle, Washington USA (2012) (0)
- Abstract 4969: TIGIT pathway phenotyping sheds light on promising strategies to restore anti-tumor immunity (2019) (0)
- 273 Dermato-Pulmonary syndrome associated with anti-melanoma differentiation-associated gene 5 antibodies after allogeneic hematopoietic stem cell transplantation: a monocentric retrospective study (2016) (0)
- KIR3DL2: A New Therapeutic Target for Cutaneous T-Cell Lymphomas? (2015) (0)
- Quantifying response to various treatments using the revisited blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker. (2021) (0)
- 37. ANGIOTROPISM IS AN INDEPENDENT PREDICTOR OF MICROSCOPIC SATELLITES IN PRIMARY CUTANEOUS MELANOMA (2013) (0)
- IL-4/IL-13 inhibitors for atopic dermatitis induce psoriatic rash transcriptionally close to pustular psoriasis. (2023) (0)
- Prise en charge des herpès HSV2 pseudotumoraux au cours de l’infection par le virus VIH : 10 observations (2011) (0)
- Immunsuppression in der Dermatologie und PML (2009) (0)
- The EORTC Cutaneous T-Cell Lymphoma (CTCL) Platform (2010) (0)
- Bcl-2 protein expression is the strongest independent prognostic factor of survival in Primary Cutaneous Large B-Cell Lymphomas (Short title: bcl-2 expression in Primary Cutaneous Large B-cell Lymphomas) (2004) (0)
- French real-life retrospective study in patients with mycosis fungoides and Sezary syndrome treated by mogamulizumab (2021) (0)
- Mogamulizumab-induced vitiligo: 3 cases (2021) (0)
- [Dermatologic aspects of T-cell leukemia-lymphoma in adults]. (1996) (0)
- ICOSL: a new diagnostic marker and a new therapeutic target using an ICOS-Fc construct in Sézary syndrome? (2022) (0)
- Contents, Vol. 181, 1990 (1990) (0)
- Clinical characteristics of Mycosis fungoides palmaris et plantaris: two cases and a systematic literature review (2022) (0)
- [Granulomatous slack skin associated with metastatic testicular seminoma]. (2017) (0)
- [What's new in oncodermatology?]. (2009) (0)
- Serum infliximab levels and clinical response in hidradenitis suppurativa (2023) (0)
- of survival in Primary Cutaneous Large B-Cell Lymphomas Bcl-2 protein expression is the strongest independent prognostic factor (2013) (0)
- Abstract 464: AAC-11 survival pathways as therapeutic target in cancer: AAC-11 leucine-zipper domain derived peptides exert potent antitumor effects and exhibit favorable stability, pharmacokinetic and toxicology profiles (2023) (0)
- Indolent primary cutaneous T-cell gamma delta lymphomas: a first illustrated series of 5 cases. (2021) (0)
- [Pagetoid lymphoma of the Ketron-Goodman type]. (1989) (0)
- IPH 4102 , aHumanizedKIR 3 DL 2 Antibodywith Potent Activity against Cutaneous T-cell Lymphoma (2014) (0)
- The PROCLIPI study; a prototype registry for rare disease with global collaboration for establishment of a prognostic index in mycosis fungoides and Sezary syndrome (2018) (0)
- Challenges in the diagnosis of CD30+ anaplastic large-cell lymphoma (2019) (0)
- [Primary pigmented breast adenocarcinoma in a male patient]. (2013) (0)
- Differential effects of CD101 and CD80/CD86 in T cell activation through skin dendritic cells (1998) (0)
- [Exanthema and erythroderma in adults]. (2021) (0)
- [Acral melanoma in a patient with hereditary keratoderma of the palms and soles (mal de Meleda): A chance association?] (2019) (0)
- Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model (2022) (0)
- Abstract 3644: Targeting the CD51/TGF-beta pathway: a potential innovative cancer immunotherapy in T-cell lymphomas (2023) (0)
- Chimerized Anti-ICOS 314.8 Monoclonal Antibodies Inhibit Tumor Cells and Regulatory T Cells in Patients with Sézary Syndrome (2021) (0)
- A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody (TM) ARGX-110 (2016) (0)
- Cutaneous T-cell lymphomas: time for new therapeutic perspectives (2008) (0)
- 465 Cutaneous T-cell lymphoma cells release proapoptotic Fas ligand in lysosomal secretory vesicles (2019) (0)
- Palliative Radiotherapy for Disfiguring Mycosis Fungoides Lesion: A Key Treatment to Reduce Psychological and Social Impact (2018) (0)
- Malignant, benign conventional and regulatory T immune compartments in 36 patients treated with mogamulizumab for advanced CTCL (2019) (0)
- Blaschko-linear lichen planus of the face: A retrospective study of 6 cases and a literature review. (2021) (0)
- Secretomic and proteomic analysis of cutaneous T cell lymphoma-associated fibroblasts (2021) (0)
- Lymph node imaging and correlation with histological N-class: results from the PROCLIPI study show sum of the product of dimensions is the better predictor than single axis measurements (2019) (0)
- [Mid-face malignant T-cell lymphoma (old malignant granuloma). A series of 4 cases with immunophenotyping and genotype study]. (1992) (0)
- 467 Immunological signature of amyopathic dermatomyositis (2017) (0)
- Isolation of a CD8αα HLA-A2 restricted autoreactive tumor T-cell subclone from a CD4+CD8- cutaneous T-cell lymphoma (1998) (0)
- Means for diagnosis and treatment of CTCL (2001) (0)
- Hailey-Hailey disease treated with naltrexone: a question of dosage? (2022) (0)
- [When CRAF takes over BRAF in melanoma]. (2011) (0)
- 664 Biological activities of traditional medicinal herbs on skin cells (2019) (0)
- [Syphilitic pseudocondyloma]. (2013) (0)
- Long-term clinical outcome and HAVCR2 mutations in 70 patients with subcutaneous panniculitis-like T-cell lymphoma: a study from the French Cutaneous Lymphoma Group (2019) (0)
- Focal Pegylated Liposomal Doxorubicin-Induced Urticarialike Reaction at Cutaneous Transformed Sézary Lesions. (2017) (0)
- Contemporary treatment patterns and response in relapse/refractory cutaneous T-cell lymphoma (CTCL) in clinical practice in France, Germany Italy, Spain and the United Kingdom (2019) (0)
- [Penile intra-epithelial neoplasia]. (2018) (0)
- Anti-tumor effect of anti-apoptosis clone 11 protein-derived peptides on Sézary syndrome malignant CD4+ T lymphocytes (2021) (0)
- Abstract 4733: Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T Cell Lymphomas . (2013) (0)
- Dyskeratosis of the Face: A Quiz. (2016) (0)
- [Non-epidermotropic cutaneous lymphomas]. (1987) (0)
- Linfomas cutáneos: aporte de la clasificación OMS-EORTC (2006) (0)
- Physiopathology, classification and treatment of cutaneous lymphomas (2005) (0)
- [Cutaneous lesions disclosing chronic myelomonocytic leukemia]. (1992) (0)
- 614 Modulation of NK cell activation by calcium from alginate dressings in vitro (2022) (0)
- Use of central venous catheters in recessive dystrophic epidermolysis bullosa and risk of catheter‐related thrombosis: a retrospective cohort study (2022) (0)
- 160 In vivo investigation of stratum corneum thickness and epidermal barrier structure: Links with inflammatory status (2017) (0)
- An international multi-institutional study for the evaluation of folliculotropic mycosis fungoides: results of the Consensus Histopathologic Review (2019) (0)
- 046 Vitamin D3 promotes human Th2 responses by TSLP-dependent and -independent regulation of dendritic cells (2019) (0)
- [Oesophageal bullous detachment with massive haemorrhage revealing acquired haemophilia A in autoimmune bullous dermatosis]. (2019) (0)
- [A buttock lesion present for one year]. (2009) (0)
- Suppurations intra-chéloïdiennes : étude descriptive (2017) (0)
- Macrophage-derived CXCL9 and CXCL11 recruit CD8 T cells in skin and provide long-term disease control in mogamulizumab-treated CTCL patients (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Martine Bagot?
Martine Bagot is affiliated with the following schools:
